pathogenic exon-trapping sva retrotransposon rescue fukuyama muscular dystrophy 
fukuyama muscular dystrophy fcmd; mim253800 one common autosomal recessive disorders japan first human disease found result ancestral insertion sine-vntr-alu sva retrotransposon causative gene1- fcmd sva insertion occurs untranslated region utr fukutin gene pathogenic mechanism fcmd unknown effective clinical treatments exist show aberrant messenger rna mrna splicing induced sva exon-trapping underlies molecular pathogenesis fcmd quantitative mrna analysis pinpointed region missing transcripts patients fcmd region spans part end fukutin coding region proximal part utr sva insertion correspondingly fukutin mrna transcripts patients fcmd sva knock-in model mice shorter expected length sequence analysis revealed abnormal splicing event provoked strong acceptor site sva rare alternative donor site fukutin exon resulting product truncates fukutin carboxy c terminus adds amino acids encoded sva introduction antisense oligonucleotides aons targeting splice acceptor predicted exonic splicing enhancer intronic splicing enhancer prevented pathogenic exon-trapping sva cells patients fcmd model mice rescuing normal fukutin mrna expression protein production aon treatment also restored fukutin functions including o-glycosylation alpha-dystroglycan alpha-dg laminin binding alpha-dg moreover observe exon-trapping sva insertions associated disease hypercholesterolemia4 neutral lipid storage disease5 human-specific sva insertion novel gene thus although splicing sva known6- discovered human disease role sva-mediated exon-trapping demonstrated promise splicing modulation therapy first radical clinical treatment fcmd sva-mediated diseases 
